IRAADD: International Research Alliance for Antibiotic Discovery and Development Network

The IRAADD network includes internationally renowned groups with excellent track records in AMR research focusing on early stages of antibiotic discovery and development. The expert team includes natural products researchers, medical microbiologists, bio-informaticians, medicinal chemists and target-based drug designers as well as AMR Insights and a few advisory partners including global alliances focusing on antibiotic development such as DNDi/GARDP and IMI-ENABLE. The partners of the network shall set up a cooperative platform that will allow the sharing of scientific research data, translational knowledge and expert advice for the strategic development of new and advanced projects with the aim to take collaborative scientific research in the early stages of antibiotics discovery and development to a new level. The network will represent a consortium of leaders from academia and further sectors who will actively address the worldwide concern of spreading AMR. The initiative is perfectly aligned with the current “One Health Action Plan against Antimicrobial Resistance” introduced by the European Commission.